Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1985 Apr;201(4):465–469. doi: 10.1097/00000658-198504000-00011

Predicting the risk of abdominal disease in Hodgkin's lymphoma. A multifactorial analysis of staging laparotomy results in 255 patients.

M C Trotter, G A Cloud, M Davis, S P Sanford, M M Urist, S J Soong, N B Halpern, W A Maddox, C M Balch
PMCID: PMC1250735  PMID: 3977447

Abstract

There were 425 consecutive patients treated for Hodgkin's disease at this Medical Center from 1943 to 1983. Of these, 255 patients underwent a staging laparotomy and had complete preoperative clinical records. Overall, 35% had a change in stage (24% were upstaged, 11% downstaged). Twenty-nine per cent of clinical stage I patients were upstaged; 31% of stage II patients were upstaged, while less than 1% were downstaged; and four per cent of stage III patients were upstaged while 44% were downstaged. The diagnostic laparotomy yielded involvement in the spleen in 71% of patients with abdominal involvement, in the periaortic lymph nodes in 41%, in the liver in 11%, and the bone marrow in seven per cent. Only 12% of the 135 patients with negative laparotomies subsequently relapsed in the abdomen after a mean follow-up of 4.8 years. A multifactorial analysis was performed to identify dominant factors predicting the risk for abdominal disease. The factors best predicting abdominal involvement in stage I and II patients were: antecedent symptoms (greater than or equal to 2, 1, 0; p less than 0.00001), histological type [nodular sclerosing (NS) less than lymphocyte-predominant (LP) less than mixed cellularity (MC) less than lymphocyte-depleted (LD); p = 0.0009], and sex (females less than males, p = 0.01). The clinical stage (I vs. II), the site of lymphoma presentation, and the age and race of the patient did not have significant predictive value for the risk of abdominal disease after the other factors were accounted for. A mathematical model was derived for identifying dominant prognostic factors for predicting the risk of abdominal disease in an individual patient setting. The lowest risk patients were asymptomatic females with NS histology (6%) or LP histology (8%), while the highest risk patients were men with multiple symptoms and either MC histology (85%) or LD histology (93%). This information can be useful in making clinical decisions in Hodgkin's lymphoma patients, especially those at an increased risk for surgery.

Full text

PDF
465

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett M. H., MacLennan K. A., Easterling M. J., Vaughan Hudson B., Jelliffe A. M., Vaughan Hudson G. The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: an analysis of 271 non-laparotomised cases (BNLI report no. 22). Clin Radiol. 1983 Sep;34(5):497–501. doi: 10.1016/s0009-9260(83)80148-2. [DOI] [PubMed] [Google Scholar]
  2. Bergsagel D. E., Alison R. E., Bean H. A., Brown T. C., Bush R. S., Clark R. M., Chua T., Dalley D., DeBoer G., Gospodarowicz M. Results of treating Hodgkin's disease without a policy of laparotomy staging. Cancer Treat Rep. 1982 Apr;66(4):717–731. [PubMed] [Google Scholar]
  3. Cannon W. B., Nelsen T. S. Staging of Hodgkin's disease: a surgical perspective. Am J Surg. 1976 Aug;132(2):224–230. doi: 10.1016/0002-9610(76)90052-0. [DOI] [PubMed] [Google Scholar]
  4. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  5. Ferguson D. J., Allen L. W., Griem M. L., Moran M. E., Rappaport H., Ultmann J. E. Surgical experience with staging laparotomy in 125 patients with lymphoma. Arch Intern Med. 1973 Mar;131(3):356–361. [PubMed] [Google Scholar]
  6. Fuller L. M., Hutchison G. B. Collaborative clinical trial for stage I and II Hodgkin's disease: significance of mediastinal and nonmediastinal disease in laparotomy- and non-laparotomy-staged patients. Cancer Treat Rep. 1982 Apr;66(4):775–787. [PubMed] [Google Scholar]
  7. Gamble J. F., Fuller L. M., Martin R. G., Sullivan M. P., Jing B. S., Butler J. J., Shullenberger C. C. Influence of staging celiotomy in localized presentations of Hodgkin's disease. Cancer. 1975 Mar;35(3):817–825. doi: 10.1002/1097-0142(197503)35:3<817::aid-cncr2820350338>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  8. Glees J. P., Barr L. C., McElwain T. J., Peckham M. J., Gazet J. C. The changing role of staging laparotomy in Hodgkin's disease: a personal series of 310 patients. Br J Surg. 1982 Apr;69(4):181–187. doi: 10.1002/bjs.1800690402. [DOI] [PubMed] [Google Scholar]
  9. Griffin T., Gerdes A., Parker R., Taylor E., Hafermann M., Taylor W., Tesh D. Are pelvic irradiation and routine staging laparotomy necessary in clinically staged IA and IIA Hodgkin's disease? Cancer. 1977 Dec;40(6):2914–2916. doi: 10.1002/1097-0142(197712)40:6<2914::aid-cncr2820400623>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  10. Hoppe R. T., Cox R. S., Rosenberg S. A., Kaplan H. S. Prognostic factors in pathologic stage III Hodgkin's disease. Cancer Treat Rep. 1982 Apr;66(4):743–749. [PubMed] [Google Scholar]
  11. Johnson R. E., Zimbler H., Berard C. W., Herdt J., Brereton H. D. Radiotherapy results for nodular sclerosing Hodgkin's disease after clinical staging. Cancer. 1977 Apr;39(4):1439–1444. doi: 10.1002/1097-0142(197704)39:4<1439::aid-cncr2820390414>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  12. Jones S. E. Importance of staging in Hodgkin's disease. Semin Oncol. 1980 Jun;7(2):126–135. [PubMed] [Google Scholar]
  13. Kawarada Y., Goldberg L., Brady L., Pavlides C., Matsumoto T. Staging laparotomy for Hodgkin's disease. Am Surg. 1976 May;42(5):332–345. [PubMed] [Google Scholar]
  14. Lacher M. J. Primary treatment of Hodgkin's disease with sequential radiation therapy and multidrug chemotherapy without initial laparotomy--splenectomy. Prog Clin Cancer. 1982;8:283–297. [PubMed] [Google Scholar]
  15. Larson R. A., Ultmann J. E. The strategic role of laparotomy in staging Hodgkin's disease. Cancer Treat Rep. 1982 Apr;66(4):767–774. [PubMed] [Google Scholar]
  16. Martin J. K., Jr, Clark S. C., Beart R. W., Jr, ReMine W. H., White W. L., Ilstrup D. M. Staging laparotomy in Hodgkin's disease: Mayo Clinic experience. Arch Surg. 1982 May;117(5):586–591. doi: 10.1001/archsurg.1982.01380290048009. [DOI] [PubMed] [Google Scholar]
  17. Rosenstock J. G., D'Angio G. J., Kiesewetter W. B. Proceedings: The incidence of complications following staging laparotomy for Hodgkin's disease in children. Am J Roentgenol Radium Ther Nucl Med. 1974 Mar;120(3):531–535. doi: 10.2214/ajr.120.3.531. [DOI] [PubMed] [Google Scholar]
  18. Sandusky W. R., Jones R. C., Jr, Horsley J. S., 3rd, Marsh W. L., Jr, Tillack T. W., Tegtmeyer C. J., Hess C. E. Staging laparotomy in Hodgkin's disease. Ann Surg. 1978 May;187(5):485–489. doi: 10.1097/00000658-197805000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Stein R. S., Hilborn R. M., Flexner J. M., Bolin M., Stroup S., Reynolds V., Krantz S. Anatomical substages of stage III Hodgkin's disease: implications for staging, therapy, and experimental design. Cancer. 1978 Aug;42(2):429–436. doi: 10.1002/1097-0142(197808)42:2<429::aid-cncr2820420208>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  20. Urlaub B. J., Mack E. Evaluation and complications of 107 staging laparotomies for Hodgkin's disease. Ann Surg. 1979 Jul;190(1):45–47. doi: 10.1097/00000658-197907000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES